Cover Image

Optimising neonatal antiretroviral therapy using raltegravir: a qualitative analysis of healthcare workers' and caregivers' perspectives

Background In 2020, Zimbabwe adopted the WHO's recommendation to use raltegravir (RAL) granule-based regimens for treatment of neonates identified with HIV at the time of birth testing. This study explores the acceptability of RAL granules by caregivers and healthcare workers (HCWs).Methods Int...

Full description

Saved in:

Bibliographic Details
Main Authors:	Angela Mushavi (Author), Leila Katirayi (Author), Carl Stecker (Author), Precious Andifasi (Author), Pradisha Tiwari (Author), Chioniso Jakazi (Author), Talent Maphosa (Author), Viva Thorsen (Author), Mildrate Murandu (Author), Gladys Gombakomba (Author), More Mungati (Author), Lise Denoeud-Ndam (Author), Emilia Rivadeneira (Author), Rachel Weber (Author), Susan Hrapcak (Author)
Format:	Book
Published:	BMJ Publishing Group, 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Raltegravir in the management of HIV-infected patients
by: Hans-Jürgen Stellbrink
Published: (2008)

Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008)

Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
by: Xue Zhang, et al.
Published: (2019)

Dissolution Enhancement of Raltegravir by Hot Melt Extrusion Technique
by: Ahmed S. Abdul Jabbar
Published: (2018)

Understanding gender differences of people with HIV newly diagnosed or returning to care with advanced HIV disease in Malawi: a qualitative study
by: Leila Katirayi, et al.
Published: (2023)

Clinical utility of raltegravir for the treatment of HIV infection in children and adolescents
by: Nuttall J, et al.
Published: (2013)

Raltegravir for HIV-1 infected children and adolescents: efficacy, safety, and pharmacokinetics
by: Larson KB, et al.
Published: (2013)

Decentralisation and integration of paediatric tuberculosis services to primary healthcare facilities as an approach to optimise management in Cameroon and Kenya: a descriptive cohort study
by: Boris Tchounga, et al.
Published: (2024)

Evaluation of the Maternal Death Surveillance and response system in Hwange District, Zimbabwe, 2017
by: Mpumelelo Maphosa, et al.
Published: (2019)

Maternal-Neonatal Raltegravir Population Pharmacokinetics Modeling: Implications for Initial Neonatal Dosing
by: Jos Lommerse, et al.
Published: (2019)

Physiologically Based Pharmacokinetic Modelling of UGT Substrate Drugs Lamotrigine and Raltegravir during Pregnancy
by: Monika Berezowska, et al.
Published: (2024)

Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients
by: Philippe Halfon, et al.
Published: (2018)

Understanding health systems challenges in providing Advanced HIV Disease (AHD) care in a hub and spoke model: a qualitative analysis to improve AHD care program in Malawi
by: Thulani Maphosa, et al.
Published: (2024)

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission
by: Thanyawee Puthanakit, et al.
Published: (2018)

Antiretroviral therapy containing raltegravir to prevent mother-to-child transmission of HIV in infected pregnant women
by: Diego M. Cecchini, et al.
Published: (2017)

Acceptability and usability of a paediatric HIV screening tool in high-volume outpatient settings in Malawi, perspectives from caregivers and healthcare workers
by: Alice Maida, et al.
Published: (2023)

High rates of burnout among maternal health staff at a referral hospital in Malawi: A cross-sectional study
by: Meguid Tarek, et al.
Published: (2011)

HIV-1 resistance patterns to integrase inhibitors in Chilean patients with virological failure on raltegravir-containing regimens
by: Pablo Ferrer, et al.
Published: (2020)

Selective and rapid determination of raltegravir in human plasma by liquid chromatographyâtandem mass spectrometry in the negative ionization mode
by: Ajay Gupta, et al.
Published: (2015)

ASSESSMENT OF ECONOMIC EFFICIENCY OF APPLICATION OF RALTEGRAVIR BY PATIENTS WITHOUT EXPERIENCE OF TYPE 1 HIV INFECTION THERAPY IN RUSSIA
by: Elamin H. Elbasha, et al.
Published: (2015)

Efficacy and Safety of Raltegravir-Based Dual Therapy in AIDS Patients: A Meta-Analysis of Randomized Controlled Trials
by: Yinqiu Huang, et al.
Published: (2019)

Pharmacoeconomic analysis of the etravirine compared to raltegravir in treatment HIV-infected adult patients, previously treated with antiretroviral drugs
by: Y. I. Ashikhmin, et al.
Published: (2018)

"I feel myself incomplete, and I am inferior to people": experiences of Sudanese women living with obstetric fistula in Khartoum, Sudan
by: Salma A. E. Ahmed, et al.
Published: (2019)

Correction to: "I feel myself incomplete, and I am inferior to people": experiences of Sudanese women living with obstetric fistula in Khartoum, Sudan
by: Salma A. E. Ahmed, et al.
Published: (2020)

"I am a person but I am not a person": experiences of women living with obstetric fistula in the central region of Malawi
by: Josephine Changole, et al.
Published: (2017)

Using the critical path method to rollout and optimise new PMTCT guidelines to eliminate mother-to-child transmission of HIV in Zimbabwe: a descriptive analysis
by: Reuben Musarandega, et al.
Published: (2020)

A population pharmacokinetics analysis assessing the exposure of raltegravir once‐daily 1200 mg in pregnant women living with HIV
by: Vera E. Bukkems, et al.
Published: (2021)

Markers of HIV reservoir size and immune activation after treatment in acute HIV infection with and without raltegravir and maraviroc intensification
by: Jintanat Ananworanich, et al.
Published: (2015)

Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV-In Vitro and In Vivo Evaluation
by: Heba S. Abd-Ellah, et al.
Published: (2023)

Fármacos recentes usados para o tratamento da infecção pelo HIV-1: enfuvirtida, maraviroc, raltegravir e etravirina
by: M.A. Brito
Published: (2011)

Inhibidores de la integrasa y raltegravir en el manejo de la infección por virus de la inmunodeficiencia humana en la era de la resistencia a múltiples medicamentos Integrase Inhibitors and raltegravir use in the management of HIV infection in the era of multidrug resistance
by: Fredy Guevara, et al.
Published: (2010)

The drive to generate multiple forms of oncogenic cyclin D1 transcripts in mantle cell lymphoma
by: Chioniso Patience Masamha
Published: (2017)

Urinary Eicosanoid Metabolites in HIV-Infected Women with Central Obesity Switching to Raltegravir: An Analysis from the Women, Integrase, and Fat Accumulation Trial
by: Todd Hulgan, et al.
Published: (2014)

Optimisation Algorithms and Swarm Intelligence
Published: (2022)

Optimising the Outcome of Embryo Transfer
by: Sunita Tandulwadkar, et al.
Published: (2019)

Optimising the management of trachomatous trichiasis
by: Anthony W Solomon
Published: (2016)

The difficulty with responding to policy changes for HIV and infant feeding in Malawi
by: de Paoli Marina, et al.
Published: (2010)

How to optimise public health interventions: a scoping review of guidance from optimisation process frameworks
by: Sam McCrabb, et al.
Published: (2020)

METACOMMUNICATION IN THE CONTEXT OF SPEECH INFLUENCE OPTIMISATION
by: Sergiy Kryvoruchko, et al.
Published: (2019)

Optimisation Models and Methods in Energy Systems
by: Antunes, Carlos Henggeler
Published: (2019)